{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:22:25Z","timestamp":1793989345354,"version":"4.8.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2019-12369984"],"award-info":[{"award-number":["RF-2019-12369984"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","award":["CPDA110795"],"award-info":[{"award-number":["CPDA110795"]}],"id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG2017-ID 20361"],"award-info":[{"award-number":["IG2017-ID 20361"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007343","name":"Universit\u00e0 degli Studi di Brescia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.molmet.2024.101889","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T20:25:52Z","timestamp":1706819152000},"page":"101889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The protease activated receptor 2 - CCAAT\/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis"],"prefix":"10.1016","volume":"81","author":[{"given":"Gianmarco","family":"Villano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Novo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Turato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santina","family":"Quarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Ruvoletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Biasiolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Protopapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Chinellato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Trevellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marnie","family":"Granzotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Cannito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cendron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"De Siervi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Parola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Vettor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2077-9202","authenticated-orcid":false,"given":"Patrizia","family":"Pontisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2024.101889_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.molmet.2024.101889_bib2","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.clinre.2015.05.005","article-title":"Liver fibrosis: common mechanisms and antifibrotic therapies","volume":"39","author":"Schuppan","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.molmet.2024.101889_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol Aspect Med"},{"key":"10.1016\/j.molmet.2024.101889_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases -diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.molmet.2024.101889_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/joim.13380","article-title":"Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies","volume":"291","author":"Lee","year":"2022","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.molmet.2024.101889_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.semcdb.2016.09.005","article-title":"SERPINB3 and B4: from biochemistry to biology","volume":"62","author":"Sun","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.molmet.2024.101889_bib7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/labinvest.2010.55","article-title":"SERPINB3 modulates TGF-\u03b2 expression in chronic liver disease","volume":"90","author":"Turato","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.molmet.2024.101889_bib8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2893.2007.00935.x","article-title":"Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis","volume":"15","author":"Biasiolo","year":"2008","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.molmet.2024.101889_bib9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.bjc.6601543","article-title":"Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma","volume":"90","author":"Pontisso","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.molmet.2024.101889_bib10","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/cncr.21106","article-title":"Squamous cell carcinoma antigen immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma","volume":"103","author":"Beneduce","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.molmet.2024.101889_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/jcp.2007.051383","article-title":"Squamous cell carcinoma antigen in human liver carcinogenesis","volume":"61","author":"Guido","year":"2008","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.molmet.2024.101889_bib12","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1038\/s41598-017-03744-3","article-title":"SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells","volume":"7","author":"Novo","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.molmet.2024.101889_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.910526","article-title":"SerpinB3 as a pro-inflammatory mediator in the progression of experimental non-alcoholic fatty liver disease","volume":"13","author":"Novo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.molmet.2024.101889_bib14","doi-asserted-by":"crossref","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et\u00a0al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 2023; S0168-S8278(23)00418-X. doi: 10.1016\/j.jhep.2023.06.003.","DOI":"10.1016\/j.jhep.2023.06.003"},{"key":"10.1016\/j.molmet.2024.101889_bib15","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2021.04.074","article-title":"Preparing for the NASH epidemic: a call to action","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2024.101889_bib16","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2024.101889_bib17","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2024.101889_bib18","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.molmet.2024.101889_bib19","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.18632\/oncotarget.2943","article-title":"Hypoxia up-regulates SERPINB3 through HIF-2\u03b1 in human liver cancer cells","volume":"6","author":"Cannito","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.molmet.2024.101889_bib20","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.3390\/cancers11121933","article-title":"SerpinB3 differently up-regulates hypoxia inducible factors -1\u03b1 and -2\u03b1 in hepatocellular carcinoma: mechanisms revealing novel potential therapeutic targets","volume":"11","author":"Cannito","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.molmet.2024.101889_bib21","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1128\/MCB.00200-09","article-title":"Hypoxia-inducible factor 2 regulates hepatic lipid metabolism","volume":"29","author":"Rankin","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.molmet.2024.101889_bib22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.24400","article-title":"Hypoxia-inducible transcription factor 2a promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis","volume":"54","author":"Qu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2024.101889_bib23","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/hep.29754","article-title":"Hypoxia inducible factor 2a drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein","volume":"67","author":"Morello","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2024.101889_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jcmgh.2021.10.002","article-title":"Hepatocyte-specific deletion of HIF2\u03b1 prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation","volume":"13","author":"Foglia","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.molmet.2024.101889_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrendo.2017.56","article-title":"Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance","volume":"13","author":"Meex","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.molmet.2024.101889_bib26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2020.10.030","article-title":"Hepatokines and adipokines in NASH-related hepatocellular carcinoma","volume":"74","author":"Kucukoglu","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.molmet.2024.101889_bib27","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2015.09.023","article-title":"Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism","volume":"22","author":"Meex","year":"2015","journal-title":"Cell Metabol"},{"key":"10.1016\/j.molmet.2024.101889_bib28","series-title":"An SCCA -1 production inhibitor comprising 1-piperidinepropionic acid and\/or a salt thereof as an active ingredient","author":"Toshihiko","year":"2009"},{"key":"10.1016\/j.molmet.2024.101889_bib29","series-title":"SerpinB3 inhibitor for the control of fibrosis and steatohepatitis","author":"Pontisso","year":"2018"},{"key":"10.1016\/j.molmet.2024.101889_bib30","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/ph16101486","article-title":"1-Piperidine propionic acid as an allosteric inhibitor of protease activated receptor-2","volume":"16","author":"Chinellato","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.molmet.2024.101889_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.molmet.2019.08.019","article-title":"PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease","volume":"29","author":"Rana","year":"2019","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2024.101889_bib32","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/hep.32589","article-title":"PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference","volume":"76","author":"Shearer","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2024.101889_bib33","first-page":"324815","article-title":"CCAAT\/Enhancer binding protein \u03b2 in relation to ER stress, inflammation, and metabolic disturbances","author":"van der Krieken","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.molmet.2024.101889_bib34","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1111\/febs.15829","article-title":"Molecular mechanisms regulating proteinase-activated receptors (PARs)","volume":"288","author":"Chandrabalan","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.molmet.2024.101889_bib35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/bj20020508","article-title":"CCAAT\/enhancer-binding proteins: structure, function and regulation","volume":"365","author":"Ramji","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.molmet.2024.101889_bib36","doi-asserted-by":"crossref","first-page":"37319","DOI":"10.1074\/jbc.M113.492793","article-title":"Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-\u03b2 receptor signaling pathways contributes to renal fibrosis","volume":"288","author":"Hyunjae Chung","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2024.101889_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s10020-021-00283-6","article-title":"TGF-\u03b2-induced \u03b1-SMA expression is mediated by C\/EBP\u03b2 acetylation in human alveolar epithelial cells","volume":"27","author":"Hui Ding","year":"2021","journal-title":"Mol Med"},{"key":"10.1016\/j.molmet.2024.101889_bib38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jaci.2010.10.009","article-title":"A\u00a0nonredundant role for mouse Serpinb3a in the induction of mucus production in asthma","volume":"127","author":"Sivaprasad","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.molmet.2024.101889_bib39","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1101\/gad.14.15.1920","article-title":"Translational control of C\/EBP alpha and C\/EBP beta isoform expression","volume":"14","author":"Calkhoven","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.molmet.2024.101889_bib40","doi-asserted-by":"crossref","first-page":"896-904","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.molmet.2024.101889_bib41","doi-asserted-by":"crossref","first-page":"823-33","DOI":"10.1016\/j.jhep.2019.04.019","article-title":"Report on the AASLD\/EASL joint workshop on clinical trial endpoints in NAFLD","volume":"71","author":"Rinella","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.molmet.2024.101889_bib42","first-page":"329","article-title":"Experimental and investigational targeted therapies for the management of fibrosis in NASH: an update","volume":"13","author":"Huisman","year":"2021","journal-title":"J\u00a0Exp Pharmacol"},{"key":"10.1016\/j.molmet.2024.101889_bib43","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1111\/febs.15829","article-title":"Molecular mechanisms regulating proteinase-activated receptors (PARs)","volume":"288","author":"Chandrabalan","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.molmet.2024.101889_bib44","doi-asserted-by":"crossref","first-page":"23188","DOI":"10.1074\/jbc.M116.732743","article-title":"Targeting liver fibrosis with a cell-penetrating protease-activated receptor-2 (PAR2) pepducin","volume":"291","author":"Shearer","year":"2016","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2024.101889_bib45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.arcmed.2018.12.002","article-title":"Tryptase promotes the profibrotic phenotype transfer of atrial fibroblasts by PAR2 and PPAR\u03b3 pathway","volume":"49","author":"Tan","year":"2018","journal-title":"Arch Med Res"},{"key":"10.1016\/j.molmet.2024.101889_bib46","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.ATV.0000258862.61067.14","article-title":"Membrane-type serine protease-1\/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis","volume":"27","author":"Seitz","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.molmet.2024.101889_bib47","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1073\/pnas.97.10.5255","article-title":"Tissue factor- and factor X-dependent\u00a0activation of protease-activated receptor 2 by factor VIIa","volume":"97","author":"Camerer","year":"2000","journal-title":"Proc\u00a0Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2024.101889_bib48","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood-2012-09-455436","article-title":"Hepatocyte tissue factor activates the coagulation cascade in mice","volume":"121","author":"Sullivan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.molmet.2024.101889_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102022","article-title":"Protease-activated receptor 2 induces ROS-mediated inflammation through Akt-mediated NF-\u03baB and FoxO6 modulation during skin photoaging","volume":"44","author":"Bang","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.molmet.2024.101889_bib50","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2024.101889_bib51","first-page":"202","article-title":"SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3)","volume":"19","author":"Turato","year":"2015","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"10.1016\/j.molmet.2024.101889_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00125-006-0480-4","article-title":"Increased\u00a0expression of CCAAT\/enhancer binding protein-beta and -delta and monocyte chemoattractant protein-1 genes in aortas from hyperinsulinaemic rats","volume":"50","author":"Sato","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2024.101889_bib53","first-page":"11890","article-title":"Risk factors of hepatocellular carcinoma in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"27","author":"Guo","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.molmet.2024.101889_bib54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/path.2708","article-title":"SERPINB3 induces epithelial-mesenchymal transition","volume":"221","author":"Quarta","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.molmet.2024.101889_bib55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/biology10050363","article-title":"Low P66shc with high SerpinB3 levels favors necroptosis and better survival in hepatocellular carcinoma","volume":"23","author":"Fasolato","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.molmet.2024.101889_bib56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1258\/ebm.2011.010229","article-title":"Increased antiprotease activity of the SERPINB3 polymorphic variant SCCA-PD","volume":"236","author":"Turato","year":"2011","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.molmet.2024.101889_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/srep17701","article-title":"SerpinB3 and yap interplay increases myc oncogenic activity","volume":"5","author":"Turato","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.molmet.2024.101889_bib58","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.molmet.2024.101889_bib59","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1038\/srep03056","article-title":"SERPINB3 is associated with longer survival in transgenic mice","volume":"3","author":"Villano","year":"2013","journal-title":"Sci Rep"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:35:11Z","timestamp":1761957311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877824000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":59,"alternative-id":["S2212877824000206"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2024.101889","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The protease activated receptor 2 - CCAAT\/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2024.101889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101889"}}